Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Gallbladder Neoplasms × Filgrastim × Clear all

Sponsor

Conditions

Lymphoma 58 Multiple Myeloma 52 Leukemia 47 Leukemia, Myeloid, Acute 43 Precursor Cell Lymphoblastic Leukemia-Lymphoma 40 Myelodysplastic Syndromes 36 Lymphoma, Non-Hodgkin 36 Hodgkin Disease 35 Lymphoma, Mantle-Cell 26 Lymphoma, Large B-Cell, Diffuse 26 Leukemia, Lymphocytic, Chronic, B-Cell 25 Lymphoma, Follicular 22 Breast Neoplasms 22 Burkitt Lymphoma 21 Lymphoma, B-Cell, Marginal Zone 16 Congenital Abnormalities 15 Lymphoma, Large-Cell, Immunoblastic 14 Recurrence 13 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 13 Sarcoma 12 Neoplasms, Plasma Cell 12 Hematologic Neoplasms 10 Leukemia, Myelomonocytic, Juvenile 9 Leukemia, Biphenotypic, Acute 9 Blast Crisis 9 Neoplasms 8 Leukemia, Myelomonocytic, Chronic 8 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 7 Neuroblastoma 7 Myeloproliferative Disorders 7

Interventions

Gemcitabine 18 Cisplatin 10 Capecitabine 9 Oxaliplatin 6 pembrolizumab 4 Fluorouracil 4 Sorafenib 3 Magnetic Resonance Spectroscopy 3 Leucovorin 3 Erlotinib Hydrochloride 3 trifluridine tipiracil drug combination 2 regorafenib 2 cobimetinib 2 atezolizumab 2 Trastuzumab 2 Taxes 2 Specimen Handling 2 Platinum 2 N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 2 Lapatinib 2 Biopsy 2 Bevacizumab 2 Albumin-Bound Paclitaxel 2 130-nm albumin-bound paclitaxel 2 1,2-diaminocyclohexaneplatinum II citrate 2 zanidatamab 1 varlilumab 1 vandetanib 1 tucatinib 1 trametinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡